Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective, Open-label, Biomarker Study for Early-stage Ovarian Clear Cell Carcinoma (OCCC) Patients at Risk of Recurrence

NCT06237946 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT06237946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06237946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective, Open-label, Biomarker Study for Early-stage Ovarian Clear Cell Carcinoma (OCCC) Patients at Risk of Recurrence
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 15, 2024
Completion date
December 31, 2024
Enrollment
272 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

figo stage ic2 to ii ovarian clear cell carcinoma